Direct oral anticoagulants in pediatric venous thromboembolism: Experience in specialized pediatric hemostasis centers in the United States

BACKGROUND: Before the official US Food and Drug Administration approval in 2021, pediatric hematologists across the United States have used direct oral anticoagulants (DOACs) “off-label” and based on extrapolation from labeling for adults with venous thromboembolism (VTE) and interim results of ped...

Descripción completa

Detalles Bibliográficos
Autores principales: Corrales-Medina, Fernando F., Raffini, Leslie, Recht, Michael, Santos, Jarren, Thornburg, Courtney D., Davila, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031368/
https://www.ncbi.nlm.nih.gov/pubmed/36970740
http://dx.doi.org/10.1016/j.rpth.2022.100001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031368/
https://www.ncbi.nlm.nih.gov/pubmed/36970740
http://dx.doi.org/10.1016/j.rpth.2022.100001

Ejemplares similares